Aspirin for preventing the recurrence of venous thromboembolism. - Wikidata - awgldk - TriplyDB

Aspirin for preventing the recurrence of venous thromboembolism.

Aspirin for preventing the recurrence of venous thromboembolism.

http://www.wikidata.org/entity/Q34276812

about

Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism Effective management of venous thromboembolism in the community: non-vitamin K antagonist oral anticoagulants Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: an analysis of the implications for perioperative management New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism Assessing the risk of recurrent venous thromboembolism--a practical approach Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation Recurrent venous thromboembolism: what is the risk and how to prevent it Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysis New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities Primary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the Literature Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring Management of venous thromboembolism: an update Guidance for the treatment of deep vein thrombosis and pulmonary embolism Duration of anticoagulation for venous thromboembolic events Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis The history and historical treatments of deep vein thrombosis The association of smoking with venous thrombosis in women. A population-based, case-control study Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis Platelets in pulmonary vascular physiology and pathology.Thrombosis: tangled up in NETs.Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study.Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.Evolving use of new oral anticoagulants for treatment of venous thromboembolism 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.A review on state-of-the-art data regarding safe early discharge following admission for pulmonary embolism: what do we know?Prognosis of patients with suspected pulmonary embolism in Buenos Aires: a prospective cohort study Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials.A flow cytometric analysis of the inhibition of platelet reactivity due to nitrite reduction by deoxygenated erythrocytes.Thrombo-prophylaxis in acutely ill medical and critically ill patients.Bleeding and clotting in hereditary hemorrhagic telangiectasia Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study Clinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation An unusual occurrence: a case of venous thromboembolism in pregnancy associated with heterotaxy syndrome Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study.Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

P2860

Q24197581-DD5CB87B-93AB-46C6-9EED-86F23E114A7D Q26746213-61B33817-EAAD-4EDE-86CF-0A8AF97932F6 Q26749273-C5D1858B-AE11-42FB-A9CA-211331F8AD1B Q26778757-277D0D56-2897-43C0-A2AF-822857103CA6 Q26781790-78C6779C-5DF5-40BA-8E9A-9E03A0C1D15C Q26786574-72F897EE-8706-42B8-8859-2F23C382BC9B Q26796430-CB54B4B5-B9FB-4F89-B548-B6BBDB7A3537 Q26825608-14735CCE-29F6-46D1-A690-F058CF1AC6B0 Q26826847-D24EC48C-2376-4EB5-BCA7-B8F2788D4000 Q26828750-2D973988-730A-4C9A-8898-0957AE6F265B Q27001528-0628B596-622C-4558-B830-EA356A5DD661 Q27023818-93035119-8EC4-4920-A208-289CAE1365CF Q27317154-DDF02DA9-B1D0-4B05-88FA-35D759D74982 Q28071443-2E37C699-E6FC-4D3F-B21B-0ED178667F3D Q28078989-3F16FEA9-29A9-4B48-908D-005E453C2948 Q28081375-0EC96846-EDDA-4D4C-A6EC-4298EDD920DC Q28081717-10B687D7-6509-4779-B037-58F9120A3C60 Q28282887-84D9B47F-939E-4518-9810-AA2411B85660 Q28606831-9E414383-D7AC-4038-A565-7624F09C9429 Q30652065-4E1E373D-2C97-4D4B-AAC5-975C7CE08D0B Q33404240-77298D9D-CD12-4E02-AA56-ABAC375E3C03 Q33556910-1D3ADB96-FA18-4367-BDE0-9E87DFDEE3CE Q33724809-EB06C4AB-E4ED-433F-AB91-4B140B531D50 Q33748053-1C3B7ECE-37FC-4CB4-B896-D713A248A219 Q34047821-DCF4542B-D277-4DD1-8F9E-A4C1F4552ADC Q34436061-2E56837A-0E3A-46D1-A1C2-58D3A8110BCD Q34536091-2FCDB345-4518-45BB-A557-BCF0255621D8 Q34747244-47AD615F-D675-463A-B782-F6511F3546DD Q34761966-A0979D3E-B80D-4D55-AA96-1F6AFF56E4F5 Q34787240-CD7E27AC-4037-42D4-9DC8-103505358D0F Q35124111-CBD5B68F-B4B1-4531-B499-8CCE5AA880E2 Q35199938-9A68C7B7-B105-4A63-9EC5-99700BF74BF8 Q35335836-588AA5A0-2ECD-40DE-9046-A6B83B4727CE Q35624965-6F4EBBA9-FF1B-4FC9-97BB-1AE94C647871 Q35638248-E0FFF2C5-8215-429B-98F2-62A408353521 Q35687307-A7FD708D-0B86-4A38-BC79-801D017DEFD3 Q35920759-6D1106E9-2314-4C13-9774-676D011EF99A Q36093916-B065A41B-F8A3-494B-8357-FDC6BC3B1D9F Q36201247-6E455349-8AD2-4CCE-9F34-13B6DAD6BB24 Q36276886-DF581F64-BF2D-44A4-89A6-4C91CA0156E9

P2860

Aspirin for preventing the recurrence of venous thromboembolism.

http://www.wikidata.org/entity/Q34276812

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Aspirin for preventing the recurrence of venous thromboembolism.

@ast

Aspirin for preventing the recurrence of venous thromboembolism.

@en

Aspirin for preventing the recurrence of venous thromboembolism.

@nl

type

label

Aspirin for preventing the recurrence of venous thromboembolism.

@ast

Aspirin for preventing the recurrence of venous thromboembolism.

@en

Aspirin for preventing the recurrence of venous thromboembolism.

@nl

prefLabel

Aspirin for preventing the recurrence of venous thromboembolism.

@ast

Aspirin for preventing the recurrence of venous thromboembolism.

@en

Aspirin for preventing the recurrence of venous thromboembolism.

@nl

P1433

Q34276812-81641769-C5BB-4CAB-8A26-48B0A3759A79

P1476

Q34276812-74A42F64-23DF-48D9-BDC7-4562E373C81F

P2093

Q34276812-056DF824-1FA0-4B02-8A49-DAAFA2416441

Q34276812-22CBA77D-A237-40C8-A455-D519331DF619

Q34276812-436AEB78-2D97-4D68-A9FC-D9A5DB585ACC

Q34276812-4747E3BF-8A31-484C-8C2E-25E74E98E9EB

Q34276812-4CCE52A2-CC01-4908-AC74-47860F923FCB

Q34276812-688141C2-4742-4C3B-A4B2-8EB5938FCB05

Q34276812-72A7FC42-3B0B-4300-80D5-12D44AED7D48

Q34276812-DA2E4060-BB05-428A-961B-204D8575EAEE

Q34276812-E486D470-16A6-499B-8C83-F426B38A7D42

Q34276812-E693FA2B-5C62-4C98-847C-349EBD9CDEE9

P304

Q34276812-FFE0F362-6F6E-4E14-B603-EE9F503A2F09

P31

Q34276812-14DBDE62-9F68-4637-B849-3D2D1BE48C9A

P356

Q34276812-89CC3509-8FD3-409F-B249-C1C1F500D45D

P407

Q34276812-0B529146-909F-4F60-AF9C-8C7BF19D29EF

P433

Q34276812-4A9E721D-F737-47CC-AC52-F5CF6F72B6C9

P478

Q34276812-6901021A-246A-4B49-9367-57525D27A6B7

P50

Q34276812-8C4BB745-A79E-4A91-B799-80F876221387

Q34276812-FDA2E98D-1187-4A21-AC25-F81357CB3BFA

P577

Q34276812-0561EF10-EF12-4766-836E-4FA466B73D1B

P698

Q34276812-55A1D486-A727-443C-8829-070AF65DEE41

P921

Q34276812-A7A99428-2F44-458D-A61F-608C54ADC4AF

P356

P1433

The New England Journal of Medicine

P1476

Aspirin for preventing the recurrence of venous thromboembolism.

@en

P2093

Alessandro Schenone

http://www.w3.org/2001/XMLSchema#string

Cecilia Becattini

http://www.w3.org/2001/XMLSchema#string

Elvira Grandone

http://www.w3.org/2001/XMLSchema#string

Eugenio Bucherini

http://www.w3.org/2001/XMLSchema#string

Giancarlo Agnelli

http://www.w3.org/2001/XMLSchema#string

Marco Moia

http://www.w3.org/2001/XMLSchema#string

Maria Rita Vandelli

http://www.w3.org/2001/XMLSchema#string

Marina Bianchi

http://www.w3.org/2001/XMLSchema#string

Paolo Prandoni

http://www.w3.org/2001/XMLSchema#string

Sabine Eichinger

http://www.w3.org/2001/XMLSchema#string

P304

1959-1967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1114238

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

366

http://www.w3.org/2001/XMLSchema#string

P50

Mauro Silingardi

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22621626

http://www.w3.org/2001/XMLSchema#string

P921